UNIVERSITAIR MEDISCH CENTRUM UTRECHT - Netherlands 

Ranking results:

Past rankings:

Subject specific rankings are not yet available..

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 44
As coordinator: 7
As participant: 35
Sole participant: 2
Coordinator / Participant Ratio: 0.2*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2014 1.880.083 43.213.938 8.191.364 3 5
2013 7.259.790 75.580.316 7.284.128 3 13
2012 3.762.774 41.147.488 5.004.692 1 9
2011 11.997.392 29.475.503 5.355.958 1 5
2010 11.187.685 15.403.407 5.383.600 1 3

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE37
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD32
UNIVERSITY COLLEGE LONDON25
KATHOLIEKE UNIVERSITEIT LEUVEN23
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM22
CHARITE UNIVERSITAETSMEDIZIN BERLIN21
KAROLINSKA INSTITUTE21
UNIVERSITEIT UTRECHT20
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE19
UNIVERSITEIT ANTWERPEN19
THE UNIVERSITY OF EDINBURGH18
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS17
MEDIZINISCHE UNIVERSITAET WIEN16
SERVICIO MADRILENO DE SALUD16
UNIVERSITAET ZUERICH15
STICHTING KATHOLIEKE UNIVERSITEIT14
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK13
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V13
UPPSALA UNIVERSITET13
CONSIGLIO NAZIONALE DELLE RICERCHE12
KING'S COLLEGE LONDON12
ACADEMIC MEDICAL CENTRE AMSTERDAM11
ACADEMISCH ZIEKENHUIS GRONINGEN11
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA11
MEDIZINISCHE HOCHSCHULE HANNOVER11
PFIZER LIMITED11
REGION HOVEDSTADEN11
TARTU ULIKOOL11
UNIVERSITE DE GENEVE11
UNIVERSITY OF COPENHAGEN11
UNIVERSITY OF NEWCASTLE UPON TYNE11
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE10
EUROPEAN MOLECULAR BIOLOGY LABORATORY10
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA10
INSTITUT PASTEUR10
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN10
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV10
NOVARTIS PHARMA10
UNIVERSITA DEGLI STUDI DI TORINO10
UNIVERSITAETSKLINIKUM HEIDELBERG10
UNIVERSITY OF AARHUS10
UNIVERSITY OF LEEDS10
ASTRAZENECA9
EBERHARD KARLS UNIVERSITAET TUEBINGEN9
JANSSEN PHARMACEUTICA NV9
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS9
THE UNIVERSITY OF MANCHESTER9
UNIVERSITA DEGLI STUDI DI VERONA9
UNIVERSITEIT MAASTRICHT9
UNIVERSITY OF BOLOGNA9
DANMARKS TEKNISKE UNIVERSITET8
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O8
GOETEBORGS UNIVERSITET8
KLINIKUM DER UNIVERSITAET ZU KOELN8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE8
UNIVERSITY OF BRISTOL8
UNIVERSITY OF HELSINKI8
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER8
ACADEMISCH ZIEKENHUIS LEIDEN7
EATRIS ERIC7
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON7
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN7
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS7
THE UNIVERSITY OF LIVERPOOL7
THE UNIVERSITY OF NOTTINGHAM7
UNIVERSITAET BERN7
WAGENINGEN UNIVERSITY7
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM6
BAYER6
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM6
BIOMERIEUX6
COMMISSARIAT A L'ENERGIE ATOMIQUE6
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER6
DEUTSCHES KREBSFORSCHUNGSZENTRUM6
ELI LILLY AND COMPANY LIMITED6
JULIUS CLINICAL RESEARCH BV6
LEIDS UNIVERSITAIR MEDISCH CENTRUM6
MASARYKOVA UNIVERZITA6
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU6
SANOFIAVENTIS6
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM6
STICHTING VUMC6
TAKEDA DEVELOPMENT CENTRE EUROPE6
UNIVERSITA DEGLI STUDI DI MILANO6
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA6
UNIVERSITAET ULM6
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF6
UNIVERSITY OF BIRMINGHAM6
UNIVERSITY OF GLASGOW6
UNIVERSITY OF OSLO6
UNIVERSITY OF WALES CARDIFF6
ARTTIC5
CENTRE DE REGULACIO GENOMICA5
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE5
F HOFFMANNLA ROCHE5
GLAXOSMITHKLINE BIOLOGICALS5
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT5
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI5
MEDIZINISCHE UNIVERSITAT INNSBRUCK5
NATIONAL UNIVERSITY OF IRELAND GALWAY5

Constancy:

Total number of partners: 2978
Partner loyalty:
Frequent Partner: (> 2 projects): 1503
Rare Partner: 1475
Frequent / Rare Partner Ratio: 1.02

Project overview:

Start dateProjectacronymrolefundingpartners
2014-04-09Imaging Innate Immunity of Staphylococcal Infections PSMS-IN-INFLAMMATIONcoordinator259.5831
2014-02-01Translating neuroimaging findings from research into clinical practice PSYSCANparticipant5.998.34615
2014-02-01Biomarker Development for Postoperative Cognitive Impairment in the Elderly BIOCOGparticipant5.982.40012
2014-02-01Platform foR European Preparedness Against (Re-)emerging Epidemics PREPAREparticipant23.992.37527
2014-02-01Extracellular Vesicles and exosomes from adult stem cells in the regeneration of organ injury EVESTEMINJURYparticipant1.249.7474
2014-01-01Industry-Academia exchange to further FXR-based therapeutic intervention and non-invasive diagnosis in Inflammatory Bowel Disease FXR-IBDcoordinator1.486.1003
2014-01-01Image-guided pancreatic cancer therapy IPACTparticipant5.991.0708
2014-01-01Cardio Renal Paradigms ElucidateD through an International Exchange ScheMe CARPEDIEMcoordinator134.4003
2013-12-01Advance Care Planning; an Innovative Palliative Care Intervention to Improve Quality of Life in Cancer Patients - a Multi-Centre Cluster Randomized Clinical Trial ACTIONparticipant4.784.6568
2013-11-01Long-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a genetic model of epilepsy – tuberous sclerosis complex EPISTOPparticipant9.451.67514
2013-10-01Exploitation of genomic variants affecting coronary artery disease and stroke risk for therapeutic intervention CVGENES-AT-TARGETparticipant5.995.44912
2013-10-01Advances in Small Trials dEsign for Regulatory Innovation and eXcellence ASTERIXcoordinator2.999.8817
2013-10-01The impact of chromosomal instability on health: Molecular causes and consequences of aneuploidy PLOIDYNETparticipant3.017.79011
2013-10-01Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope EU-CERT-ICDparticipant5.999.56219
2013-10-01Combined Molecular Microscopy for Therapy and Personalized Medication in Rare Anaemias Treatments COMMITMENTparticipant5.999.9829
2013-09-01Multicentre Preclinical Animal Research Team MULTI-PARTparticipant497.78112
2013-09-01Targeting and exploiting B cell functions for treatment in cardiovascular disease ATHERO-B-CELLparticipant5.892.17811
2013-09-01Functional analysis of RasGRP1 SNPs in autoimmune disease AUTOIMMUNITY RASGRP1coordinator259.7451
2013-09-01"MicroRNAs in the Pathogenesis, Treatment and Prevention of Epilepsy" EPIMIRNAparticipant11.586.85816
2013-09-01ATMP GMP Open Access Research Alliance - AGORA AGORAparticipant497.4328
2013-08-01DEVELOPMENT OF TAILORED ANTIMICROBIAL TREATMENT REGIMENS AND NOVEL HOST- PATHOGEN INSIGHTS FOR RESPIRATORY TRACT INFECTIONS AND SEPSIS TAILORED-TREATMENTparticipant5.975.3837
2013-08-01WNT-mediated signal relay in stem cells and oncogenesis - from basic biology to applications WNTSAPPcoordinator4.000.16410
2013-05-01Quantitative T cell Immunology QUANTIparticipant4.012.57012
2013-03-01Model-Driven European Paediatric Digital Repository MD PAEDIGREEparticipant11.869.00022
2012-12-01Establishment of a cross continent consortium for enhancing regenerative medicine in skeletal tissues SKELGENparticipant168.0007
2012-11-01Ultra-High Field Magnetic Resonance Imaging HIMRparticipant3.597.4408
2012-08-01Closing in on Runx3 and CXCL4 to open novel avenues for therapeutic intervention in systemic sclerosis CIRCUMVENTparticipant1.500.0001
2012-02-01European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke EuroHYP-1participant10.941.66538
2012-01-01EPIC-CVD: Individualised CVD risk assessment: tailoring targeted and cost-effective approaches to Europe's diverse populations EPIC-CVDparticipant5.987.26630
2012-01-01NPlast - A neuroscience school that aims to preserve and restore neuroplasticity in brain disorders NPlastparticipant3.954.67910
2012-01-01Implant Disposable Antibacterial Coating (I.D.A.C.): a Novel Approach to Implant-Related Infections in Orthopaedics and Trauma Surgery I.D.A.C.participant3.000.00012
2012-01-01Translational Adolescent and Childhood Therapeutic Interventions in Compulsive Syndromes TACTICSparticipant6.000.00012
2012-01-01EUropean TRanslational training for Autoimmunity & Immune manipulation Network EUTRAINcoordinator3.762.77411
2012-01-01Tissue in Host Engineering Guided Regeneration of Arterial Intimal Layer THE GRAILparticipant5.998.4389
2011-12-01Developing a global understanding of the PRC and NuRD complexes in stem cell differentiation, in health and disease 4DCELLFATEparticipant11.982.40313
2011-12-01Image Guided Local Drug Delivery from Nanocarriers using Focused Ultrasound Sound Pharmaparticipant2.500.0001
2011-11-01Epilepsy Pharmacogenomics: delivering biomarkers for clinical use EpiPGXparticipant5.997.99615
2011-10-01Gaining sage on the Epoetins' saga: assessing long term risks and advancing towards better Epoetin driven treatment modalities EpoCanparticipant2.995.10413
2011-10-01Biomarker for Cardiovascular Risk Assessment in Europe BiomarCaREparticipant6.000.00030
2011-10-01Evolution and Transfer of Antibiotic Resistance EVOTARcoordinator11.997.39218
2010-12-01Microvesicle-inspired drug delivery systems MINDSparticipant1.338.0002
2010-06-01A systems biology approach to dissect cilia function and its disruption in human genetic disease SYSCILIAparticipant11.069.08317
2010-02-01OPtimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) OPTiMiSEcoordinator11.187.68523
2010-01-01Neuroscience on Barriers in Development NEUROBIDparticipant2.996.32410

Alias institution names:

  • UNIVERSITAIR MEDISCH CENTRUM UTRECHT